INTERNATIONAL COLLABORATIVE STUDY TO COMPARE ASSAYS FOR ANTIBODIES THAT NEUTRALIZE HUMAN-IMMUNODEFICIENCY-VIRUS

被引:13
作者
VUJCIC, L
KATZENSTEIN, D
MARTIN, M
QUINNAN, G
机构
[1] NIAID,BETHESDA,MD 20205
[2] MAX VON PETTENKOFFER INST,MUNICH,GERMANY
[3] CHESTER BEATTY LABS,LONDON,ENGLAND
[4] DUKE UNIV,MED CTR,DURHAM,NC 27710
[5] NCI,BETHESDA,MD 20205
[6] CTR DIS CONTROL,ATLANTA,GA 30333
[7] UNIV MIAMI,MIAMI,FL 33152
[8] NEW ENGLAND DEACONESS HOSP,BOSTON,MA 02215
[9] UNIV SO CALIF,LOS ANGELES,CA 90089
[10] UNIV CALIF LOS ANGELES,LOS ANGELES,CA 90024
关键词
D O I
10.1089/aid.1990.6.847
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A variety of techniques are currently in use to measure antibodies that neutralize human immunodeficiency virus (HIV), and standardization of these assays is needed. Eleven laboratories participated in this comparison study of 14 methods for detection of HIV neutralizing antibodies (NA). A panel of 10 coded sera and a positive and a negative control serum were tested in each assay. The 10 coded samples included aliquots of the same sera that were distributed as positive and negative control sera, an aliquot of the WHO reference human anti-HIV-1 serum, and seven other sera from people with HIV-1 infection. Each laboratory reported features of its test methods and results. The results demonstrated excellent within laboratory and between laboratory consistency. The most important variable appeared to be the virus strain used. Cell line, conditions of neutralization or culture, method of endpoint determination, or use of VSV pseudotypes did not appear to be important variables. The results indicate that standardization of HIV-1 NA assays should be readily achievable. © 1990, Mary Ann Liebert, Inc. All rights reserved.
引用
收藏
页码:847 / 853
页数:7
相关论文
共 25 条
[1]   PERSISTENCE OF MATERNAL ANTIBODY IN INFANTS BEYOND 12 MONTHS - MECHANISM OF MEASLES-VACCINE FAILURE [J].
ALBRECHT, P ;
ENNIS, FA ;
SALTZMAN, EJ ;
KRUGMAN, S .
JOURNAL OF PEDIATRICS, 1977, 91 (05) :715-718
[2]   ROLE OF VIRUS-STRAIN IN CONVENTIONAL AND ENHANCED MEASLES PLAQUE NEUTRALIZATION TEST [J].
ALBRECHT, P ;
HERRMANN, K ;
BURNS, GR .
JOURNAL OF VIROLOGICAL METHODS, 1981, 3 (05) :251-260
[3]  
ALBRECHT P, 1984, REV INFECT DIS, V6, pS540
[4]   POLIOVIRUS AND POLIO ANTIBODY-ASSAY IN HEP-2 AND VERO CELL-CULTURES [J].
ALBRECHT, P ;
ENTERLINE, JC ;
BOONE, EJ ;
KLUTCH, MJ .
JOURNAL OF BIOLOGICAL STANDARDIZATION, 1983, 11 (02) :91-&
[5]  
BARIN F, 1985, LANCET, V2, P1387
[6]   ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS) [J].
BARRESINOUSSI, F ;
CHERMANN, JC ;
REY, F ;
NUGEYRE, MT ;
CHAMARET, S ;
GRUEST, J ;
DAUGUET, C ;
AXLERBLIN, C ;
VEZINETBRUN, F ;
ROUZIOUX, C ;
ROZENBAUM, W ;
MONTAGNIER, L .
SCIENCE, 1983, 220 (4599) :868-871
[7]   CONVENTIONAL AND ENHANCED PLAQUE NEUTRALIZATION ASSAY FOR POLIO ANTIBODY [J].
BOONE, EJ ;
ALBRECHT, P .
JOURNAL OF VIROLOGICAL METHODS, 1983, 6 (04) :193-202
[8]  
GEFFIN R, 1987, VACCINES, V87, P159
[9]  
GROOPMAN J, 1985, AIDS RES HUM RETROV, V3, P71
[10]   INFECTION OF HTLV-III/LAV IN HTLV-I-CARRYING CELLS MT-2 AND MT-4 AND APPLICATION IN A PLAQUE-ASSAY [J].
HARADA, S ;
KOYANAGI, Y ;
YAMAMOTO, N .
SCIENCE, 1985, 229 (4713) :563-566